Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...

USPS said its controllable loss was $848 million, up from $317 million in the same quarter last year as mail volume continues ...

Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and ...

Eli Lilly announced a strategic executive shuffle aimed at boosting its U.S. and global operations, especially in ...